Abstract
Rak is a nuclear tyrosine kinase containing Src homology 2 and 3 domains at its NH2 terminus. We report here that the retinoblastoma tumor susceptibility gene product pRb associates with Rak in vivo and in vitro. Rak binds to the A/B pocket region of pRb, a region that is frequently mutated in human cancer, during the G, and S phases of the cell cycle. Furthermore, Rak expression is elevated in G1, and transfection of Rak into NIH 3T3 cells results in a significant decrease in the number of emerging colonies. Thus, Rak is a tyrosine kinase with growth suppressing activity that may function, in part, through its interaction with pRb.
| Original language | English |
|---|---|
| Pages (from-to) | 3964-3968 |
| Number of pages | 5 |
| Journal | Cancer Research |
| Volume | 55 |
| Issue number | 18 |
| State | Published - Sep 15 1995 |
Funding
| Funders | Funder number |
|---|---|
| National Childhood Cancer Registry – National Cancer Institute | K08CA001625 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'The Nuclear Tyrosine Kinase Rak Associates with the Retinoblastoma Protein pRb'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver